Earnings To Watch Surgical Science Sweden AB Reports Q3 2024 Result - GuruFocus.com
| SUS Stock | SEK 148.20 0.70 0.47% |
Slightly above 61% of Surgical Science's investor base is looking to short. The analysis of current outlook of investing in Surgical Science Sweden suggests that many traders are alarmed regarding Surgical Science's prospects. Surgical Science's investing sentiment can be driven by a variety of factors including economic data, Surgical Science's earnings reports, geopolitical events, and overall market trends.
Surgical |
Earnings To Watch Surgical Science Sweden AB Reports Q3 2024 Result GuruFocus.com
Read at news.google.com
 |
Surgical Science Fundamental Analysis
We analyze Surgical Science's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgical Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgical Science based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Surgical Science is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Surgical Science Sweden Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Surgical Science stock to make a market-neutral strategy. Peer analysis of Surgical Science could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics with similar companies.
Peers
Surgical Science Related Equities
| GENO | Genovis AB | 4.34 | ||||
| MIPS | MIPS AB | 4.10 | ||||
| SECARE | Swedencare Publ | 1.67 | ||||
| HTRO | Hexatronic Group | 0.35 | ||||
| BICO | BICO Group | 2.44 |
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.